Teresa Tarragó was interviewed at "La Vanguardia", one of the most relevant newspapers with national print run. The document was published on 26th of November. Our CEO explained that she decided to found Iproteos upon the discovery of a drug candidate with interesting applications for the pharmaceutical industry. This final client needs to have the certainty that the compound has minimum risk, and therefore, expensive experiments are required. For that reason, “a molecule has very little value in a basic research laboratory”, Teresa affirms.